Treatment of hyperlipidemia after heart transplantation and rationale for the heart transplant lipid registry

This publication has 18 references indexed in Scilit:

• Predictive model to assess risk for cardiac allograft vasculopathy: An intravascular ultrasound study
  Journal of the American College of Cardiology, 1995
• Effect of Pravastatin on Outcomes after Cardiac Transplantation
  New England Journal of Medicine, 1995
• Lipid Lowering, Regression, and Coronary Events
  Circulation, 1995
• Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Hyperlipidemia after heart transplantation: Report of a 6-year experience, with treatment recommendations
  Journal of the American College of Cardiology, 1992
• Inhibition of growth factor signaling pathways by lovastatin
  Biochemical and Biophysical Research Communications, 1991
• Expanded Clinical Evaluation of Lovastatin (EXCEL) Study Results
  Archives of internal medicine (1960), 1991
• Reversal of lovastatin‐mediated inhibition of natural killer cell cytotoxicity by interleukin 2
  Journal of Cellular Physiology, 1990
• Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving Lovastatin
  New England Journal of Medicine, 1988
• Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
  Circulation, 1987